Healthcare of Ontario Pension Plan Trust Fund Has $1.32 Million Stake in Moelis & Company (NYSE:MC)

Healthcare of Ontario Pension Plan Trust Fund cut its holdings in shares of Moelis & Company (NYSE:MC - Free Report) by 29.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,200 shares of the asset manager's stock after selling 9,900 shares during the period. Healthcare of Ontario Pension Plan Trust Fund's holdings in Moelis & Company were worth $1,319,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of MC. Gabelli Funds LLC lifted its holdings in Moelis & Company by 3.7% during the 4th quarter. Gabelli Funds LLC now owns 26,550 shares of the asset manager's stock worth $1,490,000 after buying an additional 950 shares in the last quarter. Bridgefront Capital LLC acquired a new position in Moelis & Company during the 4th quarter worth $638,000. Winslow Asset Management Inc. lifted its holdings in Moelis & Company by 1.5% during the 4th quarter. Winslow Asset Management Inc. now owns 174,963 shares of the asset manager's stock worth $9,821,000 after buying an additional 2,593 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Moelis & Company by 11.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 3,374,385 shares of the asset manager's stock worth $189,404,000 after buying an additional 334,620 shares in the last quarter. Finally, Peak Financial Advisors LLC lifted its holdings in Moelis & Company by 2.9% during the 1st quarter. Peak Financial Advisors LLC now owns 8,715 shares of the asset manager's stock worth $495,000 after buying an additional 245 shares in the last quarter. Institutional investors and hedge funds own 91.53% of the company's stock.

Moelis & Company Trading Up 0.8 %

Shares of NYSE MC traded up $0.56 during mid-day trading on Tuesday, hitting $67.16. The company had a trading volume of 100,152 shares, compared to its average volume of 627,134. The company has a market capitalization of $5.02 billion, a PE ratio of -353.32 and a beta of 1.33. The firm has a 50-day simple moving average of $65.76 and a two-hundred day simple moving average of $59.47. Moelis & Company has a one year low of $38.58 and a one year high of $71.34.

Moelis & Company (NYSE:MC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 24th. The asset manager reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.07. The company had revenue of $264.59 million during the quarter, compared to analysts' expectations of $227.90 million. Moelis & Company had a return on equity of 4.38% and a net margin of 1.38%. Moelis & Company's revenue for the quarter was up 47.1% compared to the same quarter last year. During the same quarter last year, the company earned ($0.04) EPS. Sell-side analysts expect that Moelis & Company will post 1.08 earnings per share for the current fiscal year.

Moelis & Company Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 26th. Investors of record on Monday, August 5th were paid a $0.60 dividend. The ex-dividend date of this dividend was Monday, August 5th. This represents a $2.40 annualized dividend and a yield of 3.57%. Moelis & Company's dividend payout ratio (DPR) is currently -1,263.16%.

Insider Activity at Moelis & Company

In related news, CFO Joseph Simon sold 6,723 shares of the firm's stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $64.00, for a total value of $430,272.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Moelis & Company news, CFO Joseph Simon sold 6,723 shares of the firm's stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $64.00, for a total transaction of $430,272.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kenneth Moelis sold 5,308 shares of the firm's stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $68.87, for a total transaction of $365,561.96. Following the sale, the chief executive officer now owns 86 shares of the company's stock, valued at $5,922.82. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 12,526 shares of company stock worth $830,133. Insiders own 6.40% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Morgan Stanley increased their price target on Moelis & Company from $61.00 to $67.00 and gave the company an "underweight" rating in a research note on Monday, September 23rd. JPMorgan Chase & Co. increased their price target on Moelis & Company from $50.00 to $51.00 and gave the company a "neutral" rating in a research note on Thursday, July 25th. Keefe, Bruyette & Woods reissued a "market perform" rating and issued a $60.00 price target (up previously from $54.00) on shares of Moelis & Company in a research note on Thursday, July 25th. Wells Fargo & Company assumed coverage on Moelis & Company in a research note on Thursday, September 12th. They issued an "equal weight" rating and a $70.00 price target on the stock. Finally, UBS Group increased their price target on Moelis & Company from $47.00 to $50.00 and gave the company a "sell" rating in a research note on Tuesday, July 9th. Two research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $59.33.

About Moelis & Company

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.